EU – media

Lumendi Acquires CE-Mark on DiLumen EIP Device

UK-based medical device manufacturer, Lumendi obtained the European CE-Mark for its DiLumen Endolumenal Interventional Platform (EIP) which is used as an endoscope accessory.
- Source: The Verdict
- 908
- July 23, 2018
Company Insight endoscope EU medical device
African Swine Fever Outbreak in Romania

On Monday Romania’s national food and health safety authority reported the outbreak of African swine fever in southern Tulcea and stated that all pigs, over 44,000, would be euthanized.
- Source: Reuters
- 898
- July 3, 2018
African Swine Fever EU Market Views
Medical Devices Exploring the Impact of the New European Directive on the Pharmaceutical Industry

Pedro Pala, Clinical Trial Supply Manager, Bial, explores the implications of the new EU Clinical Trials Regulation
- Source: clinicaltrialsarena
- 958
- December 20, 2017
Directive EU polices
Apollo Endosurgery gets CE-Mark for managed weight loss system

Apollo Endosurgery has received CE-Mark for its ORBERA365 Managed Weight Loss System allowing commercialisation in the European Union (EU) and member countries of the European Economic Area.
- Source: medicaldevice-network
- 885
- September 4, 2017
CE EU New Approvals weight loss
Kite begins EU trial of CAR–T therapy

Kite Pharma has begun treating the first EU patients with its investigational CAR–T candidate, axicabtagene ciloleucel (axi-cel), in the safety expansion cohort of the ZUMA-1 trial.
- Source: pharmatimes
- 835
- August 10, 2017
CAR–T Clinical Trials Company Insight EU FDA
EU OKs first-line use of AZ’ Faslodex

EU regulators are permitting the use of AstraZeneca’s breast cancer drug Faslodex at an earlier stage of the treatment pathway in patients with certain forms of the disease.
- Source: pharmatimes
- 765
- July 28, 2017
breast cancer EU inhibitor New Approvals
Trillion in search of new partners

Trillium Therapeutics is seeking new partners as it looks over its pipeline with an eye to the future.
- Source: fiercebiotech
- 755
- July 5, 2017
EMA EU Market Views
MPs keen for close collaboration with EMA post Brexit

British MPs say they are keen to secure a close working relationship with the European Union on drug regulation post Brexit to protect patient health and investment in the UK’s life sciences sector.
- Source: pharmatimes
- 846
- July 4, 2017
Company Insight EMA EU
GSK tests mepolizumab for nasal polyps

GlaxoSmithKline has kicked off a Phase III study exploring the potential of its biologic mepolizumab in patients with severe bilateral nasal polyps, a chronic inflammatory disease of the nasal passage linings or sinuses causing soft tissue growth in the upper nasal cavity.
- Source: Pharmtimes
- 783
- June 28, 2017
Clinical Trials EU mepolizumab
GSK tests mepolizumab for nasal polyps

GlaxoSmithKline has kicked off a Phase III study exploring the potential of its biologic mepolizumab in patients with severe bilateral nasal polyps, a chronic inflammatory disease of the nasal passage linings or sinuses causing soft tissue growth in the upper nasal cavity.
- Source: pharmatimes
- 757
- June 28, 2017
asthma Company Insight EU surgery

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.